There
is
little
doubt
that
final
victories
over
pandemics,
such
as
COVID-19,
are
attributed
to
herd
immunity,
either
through
post-disease
convalescence
or
active
immunization
of
a
high
percentage
the
world's
population
with
vaccines,
demonstrating
protection
from
infection
and
transmission,
being
available
in
large
quantities
at
reasonable
prices.
However,
it
assumable
humans
immune
defects
suppression,
e.g.,
consequence
allograft
transplantation,
cannot
be
immunized
actively
nor
produce
sufficient
responses
prevent
SARS-CoV-2
infections.
These
subjects
desperately
need
other
strategies,
sophisticated
measures
immunization.
Hypertonic
salt
solutions
attack
vulnerable
core
areas
viruses,
i.e.,
denatures
surface
proteins
thus
prohibits
virus
penetration
somatic
cells.
It
has
ensured
not
affected
by
denaturation
regarding
this
unspecific
protection.
Impregnating
filtering
facepieces
hypertonic
straightforward
way
inactivate
viruses
potential
pathogens.
As
result
contact
crystals
on
facepiece,
these
pathogens
become
denatured
inactivated
almost
quantitatively.
Such
strategy
could
easily
applied
fight
against
COVID-19
pandemic
ones
may
occur
future.
Another
possible
tool
passive
antibodies
SARS-CoV-2,
preferably
human
origin.
can
harvested
patients´
sera,
which
have
successfully
survived
their
infection.
The
disadvantage
rapid
decrease
immunoglobulin
titer
after
ends
overcome
immortalizing
antibody-producing
B-cells
via
fusion
with,
mouse
myeloma
resulting
monoclonal
then
origin
in,
least
theoretically,
unlimited
amounts.
Finally,
dry
blood
spots
valuable
for
surveilling
population´s
immunity.
medRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Янв. 30, 2024
ABSTRACT
The
level
of
neutralizing
antibodies
required
to
confer
protection
against
COVID-19
breakthrough
infections
(BIs)
is
unclear,
and
the
ability
know
immune
status
individuals
rapidly
changing
endemic
variants
limited.
We
assessed
longitudinal
serum
anti-RBD
antibody
levels
activities
(NTs)
Omicron
BA.5
XBB.1.5
in
healthcare
workers
following
fourth
monovalent
fifth
bivalent
BA.4-5
vaccines.
occurrence
BIs
was
also
followed,
pre-infection
were
compared
between
patients
who
developed
BI
those
did
not.
In
addition,
we
collected
whole
blood
samples
on
same
day
as
sera
stored
them
filter
papers
(nos.
545,
590,
424)
for
up
two
months,
then
measured
their
NTs
using
dried
spots
(DBS)
eluates,
with
paired
sera.
Pre-infection
lower
than
not,
but
not
different
them.
below
50%
200-fold
diluted
might
be
one
indicators
high
risk
BI.
However,
at
6
months
after
dose
vaccine
this
threshold
almost
half
infection-naïve
participants.
DBS
eluates
strongly
correlated
sera,
time
temperature
stability
varied
type
paper;
no.
545
paper
found
most
suitable
NT
evaluation.
Diagnostic Microbiology and Infectious Disease,
Год журнала:
2024,
Номер
111(1), С. 116581 - 116581
Опубликована: Ноя. 4, 2024
The
current
SARS-CoV-2
pandemic
has
exerted
unprecedented
pressure
on
global
healthcare
systems,
with
an
urgent
demand
for
widespread
testing
to
monitor
virus
spread
and
contribute
disease
control.
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2023,
Номер
unknown
Опубликована: Фев. 7, 2023
Infant
antibody
responses
to
viral
infection
can
differ
from
those
in
adults.
However,
data
on
the
specificity
and
function
of
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
antibodies
infants,
direct
comparisons
between
infants
adults
are
limited.
We
characterized
binding
functionality
convalescent
plasma
postpartum
women
their
infected
with
SARS-CoV-2
a
vaccine-naïve
prospective
cohort
Nairobi,
Kenya.
Antibody
titers
against
Spike,
receptor
domain
N-terminal
domain,
Spike-expressing
cell-surface
staining
levels
were
significantly
higher
than
mothers.
Plasma
mothers
bound
similar
regions
Spike
S2
subunit,
including
fusion
peptide
(FP)
stem
helix-heptad
repeat
2.
displayed
more
consistent
escape
pathways
FP
region
compared
Finally,
had
antibody-dependent
cellular
cytotoxicity
(ADCC),
though,
surprisingly,
neutralization
similar.
These
results
suggest
develop
distinct
functional
repertoires
reveal
age-related
differences
humoral
immunity
that
could
be
relevant
protection
COVID-19
disease
outcomes.
There
is
little
doubt
that
final
victories
over
pandemics,
such
as
COVID-19,
are
attributed
to
herd
immunity,
either
through
post-disease
convalescence
or
active
immunization
of
a
high
percentage
the
world's
population
with
vaccines,
demonstrating
protection
from
infection
and
transmission,
being
available
in
large
quantities
at
reasonable
prices.
However,
it
assumable
humans
immune
defects
suppression,
e.g.,
consequence
allograft
transplantation,
cannot
be
immunized
actively
nor
produce
sufficient
responses
prevent
SARS-CoV-2
infections.
These
subjects
desperately
need
other
strategies,
sophisticated
measures
immunization.
Hypertonic
salt
solutions
attack
vulnerable
core
areas
viruses,
i.e.,
denatures
surface
proteins
thus
prohibits
virus
penetration
somatic
cells.
It
has
ensured
not
affected
by
denaturation
regarding
this
unspecific
protection.
Impregnating
filtering
facepieces
hypertonic
straightforward
way
inactivate
viruses
potential
pathogens.
As
result
contact
crystals
on
facepiece,
these
pathogens
become
denatured
inactivated
almost
quantitatively.
Such
strategy
could
easily
applied
fight
against
COVID-19
pandemic
ones
may
occur
future.
Another
possible
tool
passive
antibodies
SARS-CoV-2,
preferably
human
origin.
can
harvested
patients´
sera,
which
have
successfully
survived
their
infection.
The
disadvantage
rapid
decrease
immunoglobulin
titer
after
ends
overcome
immortalizing
antibody-producing
B-cells
via
fusion
with,
mouse
myeloma
resulting
monoclonal
then
origin
in,
least
theoretically,
unlimited
amounts.
Finally,
dry
blood
spots
valuable
for
surveilling
population´s
immunity.
There
is
little
doubt
that
final
victories
over
pandemics,
such
as
COVID-19,
are
attributed
to
herd
immunity,
either
through
post-disease
convalescence
or
active
immunization
of
a
high
percentage
the
world's
population
with
vaccines,
demonstrating
protection
from
infection
and
transmission,
being
available
in
large
quantities
at
reasonable
prices.
However,
it
assumable
humans
immune
defects
suppression,
e.g.,
consequence
allograft
transplantation,
cannot
be
immunized
actively
nor
produce
sufficient
responses
prevent
SARS-CoV-2
infections.
These
subjects
desperately
need
other
strategies,
sophisticated
measures
immunization.
Hypertonic
salt
solutions
attack
vulnerable
core
areas
viruses,
i.e.,
denatures
surface
proteins
thus
prohibits
virus
penetration
somatic
cells.
It
has
ensured
not
affected
by
denaturation
regarding
this
unspecific
protection.
Impregnating
filtering
facepieces
hypertonic
straightforward
way
inactivate
viruses
potential
pathogens.
As
result
contact
crystals
on
facepiece,
these
pathogens
become
denatured
inactivated
almost
quantitatively.
Such
strategy
could
easily
applied
fight
against
COVID-19
pandemic
ones
may
occur
future.
Another
possible
tool
passive
antibodies
SARS-CoV-2,
preferably
human
origin.
can
harvested
patients´
sera,
which
have
successfully
survived
their
infection.
The
disadvantage
rapid
decrease
immunoglobulin
titer
after
ends
overcome
immortalizing
antibody-producing
B-cells
via
fusion
with,
mouse
myeloma
resulting
monoclonal
then
origin
in,
least
theoretically,
unlimited
amounts.
Finally,
dry
blood
spots
valuable
for
surveilling
population´s
immunity.